Entegris: Pure, Proven, Precise Solutions

Particle contamination is one of the most consequential risks in cell therapy manufacturing. Entegris has spent decades mastering material science in the semiconductor industry, where particle control is measured at the atomic level. That same expertise now underpins a specialized life sciences portfolio built for the unique demands of cell therapy production, including advanced filtration systems and single-use manufacturing components developed through strategic acquisitions of established technology leaders.

Unlike general-purpose suppliers, Entegris brings an engineering-first perspective to contamination control. In semiconductor manufacturing, a particle failure means a scrapped wafer. In cell therapy, it can mean patient harm. The stakes are orders of magnitude higher, and the solutions need to match.

This video conversation from Phacilitate 2026 explores how Entegris is translating proven semiconductor-grade precision into practical tools for cell therapy manufacturers. Watch now to understand how a materials science approach can strengthen your particle risk mitigation strategy and support safer, more reliable manufacturing outcomes.